Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Rodriguez, Manuel S

Class:IdPerson:3000376
_displayNameRodriguez, Manuel S
_timestamp2013-01-26 21:08:03
created[InstanceEdit:3000365] May, B, 2013-01-26
firstnameManuel S
initialMS
surnameRodriguez
(author)[LiteratureReference:3000428] A proteomic study of SUMO-2 target proteins
[LiteratureReference:3215021] Strategies to Identify Recognition Signals and Targets of SUMOylation
[LiteratureReference:3222049] E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation
[LiteratureReference:8943510] Analysis of SUMOylated proteins using SUMO-traps
[LiteratureReference:8943518] Analysis of PTEN ubiquitylation and SUMOylation using molecular traps
[LiteratureReference:9834784] Phosphorylable tyrosine residue 162 in the double-stranded RNA-dependent kinase PKR modulates its interaction with SUMO
[LiteratureReference:9834840] Activation of the double-stranded RNA-dependent protein kinase PKR by small ubiquitin-like modifier (SUMO)
[LiteratureReference:9966208] Rotavirus viroplasm proteins interact with the cellular SUMOylation system: implications for viroplasm-like structure formation
[LiteratureReference:9980275] Covalent modification by SUMO is required for efficient disruption of PML oncogenic domains by Kaposi's sarcoma-associated herpesvirus latent protein LANA2
[Change default viewing format]
No pathways have been reviewed or authored by Rodriguez, Manuel S (3000376)